INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46m ago
House PTR5m ago
SEC 13F5m ago
Robinhood Chain5m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,927 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
WB
Williams Kevin BryanDirector
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,500
250.0K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

27
BB
Baggio BarbaraWIFE OF CEO
VPLMVoip-pal.com Inc
Open-market sale
SELL$2,575
250.0K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

25
DA
Dennis Phillip AndrewChief Medical Officer
NBPNovaBridge Biosciences
Open-market sale
SELL$5,606
8,494 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

25
TH
Tan Kwang HooiChief Operating Officer
FLEXFLEX LTD.
Open-market sale
SELL$862K
5,934 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

25
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$9,194
63 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

25
TH
Tan Kwang HooiChief Operating Officer
FLEXFLEX LTD.
Open-market sale
SELL$427K
2,947 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

25
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$17K
120 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$117K
806 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$71K
488 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

22
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$337K
39.8K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

21
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.13M
60.4K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TH
Tan Kwang HooiChief Operating Officer
FLEXFLEX LTD.
Open-market sale
SELL$15K
100 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$2,487
17 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
5,418 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
3,401 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$281K
4,582 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

16
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
43.1K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

15
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$119K
3,316 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

14
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
1,379 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

14
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
1,238 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

12
LL
Lin LaurenCLO, CCO and Secretary
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$41K
4,840 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

12
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$343K
2,900 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

11
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale · 10b5-1 plan
SELL$490K
81.9K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

10
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$135K
10.2K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

8
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$291K
6,680 sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

8
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$393K
9,222 sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

7
KR
Kumaraswami RaviPres. Worldwide Field Ops.
RSKDRISKIFIED LTD.
Open-market sale · 10b5-1 plan
SELL$15K
2,900 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

50
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Open-market sale
SELL$310K
1,169 sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

49
JA
Janmohamed ArifDirector
NAVNNavan, Inc.
Open-market sale
SELL$7.62M
398.5K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

47
BF
Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$160K
46.4K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$157K
590 sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

41
KA
Kampani ArjunSVP & General Counsel
RKLBRocket Lab Corp
Open-market sale
SELL$9.50M
88.0K sh
Jun 18, 2026Jun 18, 2026
traded Jun 18, 2026
+0dSEC Form 4

Evidence

39
CJ
Corso JoyChief Administrative Officer
CXMSprinklr, Inc.
Open-market sale
SELL$178K
33.6K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

39
SV
Semah VictorChief Legal Officer
HUTHut 8 Corp.
Open-market sale
SELL$1.25M
10.0K sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC Form 4

Evidence

38
JA
Janmohamed ArifDirector
NAVNNavan, Inc.
Open-market sale
SELL$898K
48.0K sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC Form 4

Evidence

38
JA
Janmohamed ArifDirector
NAVNNavan, Inc.
Open-market sale
SELL$576K
29.3K sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC Form 4

Evidence

37
HM
Holtzman MaxDirector
RYMRYTHM, Inc.
Open-market sale
SELL$80K
3,156 sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

36
ME
Marquez ElenaChief Financial Officer
ATEXAnterix Inc.
Open-market sale
SELL$341K
4,291 sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC Form 4

Evidence

36
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Open-market sale
SELL$333K
455 sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC Form 4

Evidence

35
SJ
Scott JacobGENERAL COUNSEL AND CORP. SEC.
CXMSprinklr, Inc.
Open-market sale
SELL$87K
16.4K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC Form 4

Evidence

Page 203 of 474
← PrevNext →